Publications by authors named "Vilma Decman"

Claim this Profile
P
Potential and challenges of clinical high-dimensional flow cytometry: A call to action.
Thomas Liechti, Iva Lelios, Aaron Schroeder, Vilma Decman, Christele Gonneau

Cytometry A· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2023 White Paper on Recent Issues in Bioanalysis: EU IVDR 2017/746 Implementation/Impact, IVD/CDx/CLIA Approved Assays, High Dimensional Cytometry, Multiplexing Technologies, LBA Tissue Analysis, Vaccine Study Endpoints, Cell-Based Assays for Biomarkers, Cell Therapy and Vaccines ( - Recommendations on Development & Validation of Biomarkers, IVD, CDx, Cell-Based, Flow Cytometry, Ligand-Binding and Enzyme Assays; Advanced Critical Reagents Strategies).
Olga Kholmanskikh, Yow-Ming Wang, Sarah Hersey, Meenu Wadhwa, Katherine Block, Vilma Decman

Bioanalysis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A machine learning approach toward automating spatial identification of LAG3+/CD3+ cells in ulcerative colitis.
Edward D Bonnevie, Eric Dobrzynski, Dylan Steiner, Deon Hildebrand, James Monslow, Vilma Decman

Sci Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2022 White Paper on Recent Issues in Bioanalysis: Enzyme Assay Validation, BAV for Primary End Points, Vaccine Functional Assays, Cytometry in Tissue, LBA in Rare Matrices, Complex NAb Assays, Spectral Cytometry, Endogenous Analytes, Extracellular Vesicles - Recommendations on Biomarkers/CDx, Flow Cytometry, Ligand-Binding Assays Development & Validation; Emerging Technologies; Critical Reagents Deep Characterization.
Giane Sumner, Steve Keller, James Huleatt, Roland F Staack, Leslie Wagner, Vilma Decman

Bioanalysis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The GSK Bioanalytical Hub model in bioanalysis: maximizing the synergies of co-locating various platforms in support of regulated and nonregulated study end points.
Scott G Summerfield, Huaping Tang, Vilma Decman, Lee Abberley, George Gunn

Bioanalysis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2021 White Paper on Recent Issues in Bioanalysis: ISR for Biomarkers, Liquid Biopsies, Spectral Cytometry, Inhalation/Oral & Multispecific Biotherapeutics, Accuracy/LLOQ for Flow Cytometry ( - Recommendations on Biomarkers/CDx Assays Development & Validation, Cytometry Validation & Innovation, Biotherapeutics PK LBA Regulated Bioanalysis, Critical Reagents & Positive Controls Generation).
Sarah Hersey, Steve Keller, Joel Mathews, Lindsay King, Abbas Bandukwala, Vilma Decman

Bioanalysis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
With great power comes great responsibility: high-dimensional spectral flow cytometry to support clinical trials.
Megan McCausland, Yi-Dong Lin, Tania Nevers, Christopher Groves, Vilma Decman

Bioanalysis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2020 White Paper on Recent Issues in Bioanalysis: BAV Guidance, CLSI H62, Biotherapeutics Stability, Parallelism Testing, CyTOF and Regulatory Feedback ( - Recommendations on Biotherapeutics Stability, PK LBA Regulated Bioanalysis, Biomarkers Assays, Cytometry Validation & Innovation - Regulatory Agencies' Inputs on Bioanalysis, Biomarkers, Immunogenicity, Gene & Cell Therapy and Vaccine).
Susan Spitz, Yan Zhang, Sally Fischer, Kristina McGuire, Ulrike Sommer, Vilma Decman

Bioanalysis· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best practices for the development, analytical validation and clinical implementation of flow cytometric methods for chimeric antigen receptor T cell analyses.
Ghanashyam Sarikonda, Mélissa Mathieu, Mahwish Natalia, Anil Pahuja, Qiong Xue, Vilma Decman

Cytometry B Clin Cytom· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice.
Amanda Atanasio, Vilma Decman, Derek White, Meg Ramos, Burcin Ikiz

Sci Rep· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity.
Brian J Laidlaw, Vilma Decman, Mohammed-Alkhatim A Ali, Michael C Abt, Amaya I Wolf

PLoS Pathog· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defective CD8 T cell responses in aged mice are due to quantitative and qualitative changes in virus-specific precursors.
Vilma Decman, Brian J Laidlaw, Travis A Doering, Jin Leng, Hildegund C J Ertl

J Immunol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-intrinsic defects in the proliferative response of antiviral memory CD8 T cells in aged mice upon secondary infection.
Vilma Decman, Brian J Laidlaw, Lauren J Dimenna, Sarah Abdulla, Krystyna Mozdzanowska

J Immunol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune control of HSV-1 latency.
Vilma Decman, Michael L Freeman, Paul R Kinchington, Robert L Hendricks

Viral Immunol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensory neurons regulate the effector functions of CD8+ T cells in controlling HSV-1 latency ex vivo.
Kartik Prabhakaran, Brian S Sheridan, Paul R Kinchington, Kamal M Khanna, Vilma Decman

Immunity· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression.
Vilma Decman, Paul R Kinchington, Stephen A K Harvey, Robert L Hendricks

J Virol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune control of herpes simplex virus during latency.
Kamal M Khanna, Andrew J Lepisto, Vilma Decman, Robert L Hendricks

Curr Opin Immunol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis